Brendan Melck is an analyst in the IHS Life Sciences practice.
He covers the Central and Eastern Europe region (as well as Italy
and Greece). With a background as a general business analyst
covering this region, he has built a solid understanding of the
pharmaceutical regulatory environment and the issues affecting the
industry in these countries.